Gauss

Recombinant Mouse IL-34 (carrier-free) 100 µg

Réf. UGAP : 3689435 Réf. Fournisseur : 577606 Réf. Constructeur : 577606
Recombinant Mouse IL-34 (carrier-free) 100 µg
Recombinant Mouse IL-34 (carrier-free) 100 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Mouse IL-34 shares a sequence identity of 71% with human IL-34 on the amino acid level, and the IL-34 gene is syntenic in the human, chimpanzee, rat, and mouse genomes. IL-34 has no apparent consensus structural domain or motif and does not share sequence homology with M-CSF; nevertheless, it binds to the CSFR. These two cytokines are not identical in biological activity and signal activation. IL-34 and CSF show an equivalent ability to support cell growth or survival. However, these cytokines have different ability to induce the production of chemokines (MCP-1 and eotaxin-2) in primary macrophages, the morphological change in TF-1-fms cells, and the migration of J774A.1 cells. The use of monoclonal antibodies against the CSFR suggests a differential domain binding in the receptor to IL-34 and CSF. As a result, different bioactivities and signal activation kinetics/strength are produced for these cytokines.;

En savoir plus

Garantie

Garantie 0 Mois

Description

Mouse IL-34 shares a sequence identity of 71% with human IL-34 on the amino acid level, and the IL-34 gene is syntenic in the human, chimpanzee, rat, and mouse genomes. IL-34 has no apparent consensus structural domain or motif and does not share sequence homology with M-CSF; nevertheless, it binds to the CSFR. These two cytokines are not identical in biological activity and signal activation. IL-34 and CSF show an equivalent ability to support cell growth or survival. However, these cytokines have different ability to induce the production of chemokines (MCP-1 and eotaxin-2) in primary macrophages, the morphological change in TF-1-fms cells, and the migration of J774A.1 cells. The use of monoclonal antibodies against the CSFR suggests a differential domain binding in the receptor to IL-34 and CSF. As a result, different bioactivities and signal activation kinetics/strength are produced for these cytokines.;

Caractéristiques

Fournisseur
BioLegend Europe BV
Marque
BIOLEGEND
Référence fabricant
577606
Référence distributeur
577606
Vendu par
100 μg
Quantité
N/A
Lieu de fabrication
USA
Lieu de stockage
Pays-Bas ou USA
Soumis à carboglace
non
Classement dans le catalogue fournisseur
Recombinant Protein
Certification
RUO
Type d’application
culture cellulaire
Type de produit
protéine
Température de conservation (°C)
-20 ou -70 °C
Température de transport
Blue Ice
Organisme cible
Mouse
Source biologique
CHO cells
Seuil de coupure des masses moléculaires MWCO
The 230 amino acid recombinant protein has a predicted molecular mass of 26 kD. The DTT-reduced protein migrates at approximately 39 kD and the non-reduced protein with slightly greater mobility by SDS-PAGE. Da
Concentration
10 and 25 µg sizes are bottled at 100 µg/mL. 100 µg and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration, please enter the lot number in our online tools.
Pureté
>98%, as determined by Coomassie stained SDS-PAGE. %
Matière dangereuse
Non
Code douanier
38220000
Classement NCBI
762577
Nomenclature Nacres
NA.77
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA77
Nomenclature CNRS
NA77
Nomenclature CHU
18.551
Nomenclature DGOS
LD11AOOO
Type d'échantillon
culture cellulaire
Reprise en cas d’erreur client
non